Customize your JAMA Network experience by selecting one or more topics from the list below.
In the Research Letter titled “Androgen Receptor Burden and Poor Response to Abiraterone or Enzalutamide in TP53 Wild-Type Metastatic Castration-Resistant Prostate Cancer,” which published online May 2, 2019, in JAMA Oncology,1 there was an error in Figure, B. In the Characteristic column under “Number AR perturbations,” the number “3” should be “2.” This article was corrected online.
Error in the Figure. JAMA Oncol. 2019;5(7):1070. doi:10.1001/jamaoncol.2019.2255
Coronavirus Resource Center